Ventria Bioscience

792 WordsJul 24, 20114 Pages
Case #4 Ventria Bioscience and the Controversy over Plant-Made Medicines Sinforosa Business and Society - BUS 475 Professor Filomena May 17, 2011 1.-Describe the problem facing Scott Deeter and Ventria. Deeter came to Ventria in April 2002. He was appointed as Ventria’s CEO because of his good reputation as a businessman. As CEO he helped Dr. Raymond Rodriguez sort through several projects that Ventria was working on at the time. His concept of the business was to focus on one or two projects to make Ventria a profitable business. 2.-Describe the relevant stakeholders and for each, state its interests and sources of power. Rice farmers, are more than 2000 businesses owned by families and…show more content…
5.-Describe what other options Ventria has if it chooses not to engage in dialogue or political action (or dialogue and political action are unsuccessful). Ventria’s political action didn’t work because the secretary of Agriculture ruled in favor of the farmers, millers and the public. Ventria choose to address the stakeholder's concerns. At this point, Deeter, Ventria’s CEO, decided to use protective equipment for field production, storage, and transportation. They will allow visits to their research facilities and will keep detailed records of the research. All efforts by Ventria were not satisfactory to the stakeholders and the efforts to expand where unsuccessful. In biotechnology, things always seemed to take longer (Lawrence and Weber, 2011). Ventria has a long way to go and investors are not happy. They have not been able to expand since the company started. References Pamer, M. (2004, July). Prescription Rice Message posted to California Rice Commission statical Report, May 1, 2005 Lawrence, A. T. (2008). Business and Society. In B. Gordon (Ed.), Ventria Bioscience and the Controversy over Plant-Made Medicines (Vol. Thirteenth Edition, p. 500). New York, NY: MMcGraw-Hill Irwin.

More about Ventria Bioscience

Open Document